Britain's GSK seeks U.S approval for rival to J & J's multiple myeloma drug

GlaxoSmithKline said on Monday it had applied for U.S. approval for its experimental multiple myeloma drug that showed meaningful response in nearly a third of patients, setting up a battle against Johnson& Johnson and Genmab's Darzalex.

Source: Reuters: Health - December 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news